Autopsy report · NCT00006032

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“low accrual”

The sponsor’s own words in the registry.

Life of this trial

Registered 4 months after it had already started.
Ran for about 1 year 1 month before it stopped.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sponsor type: University, hospital or other
Conditions: Breast Cancer
Interventions: etoposide; ifosfamide; topotecan hydrochloride; peripheral blood stem cell transplantation
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.